Navigation Links
Global Membrane Bioreactor (MBR) Systems Market Worth $2,052 Million by 2017

DALLAS, December 4, 2012 /PRNewswire/ --

According to the report "Membrane Bioreactor Systems Market By Types [Hollow Fiber, Flat Sheet, Multi Tubular], Configuration [Internal (Submerged/Immersed) & External (Sidestream)] & Applications [Municipal & Industrial Wastewater Treatment] - Trends & Forecasts To 2017" published by MarketsandMarkets (, MBR market was worth an estimated $746 million in 2011. This value is expected to increase at a CAGR of 14.6% during the period from 2012-2017. APAC leads the global MBR market with share of 38.7% followed by Europe and North America in terms of revenue in the year 2011.

Browse 150+ market data tables/figures spread through 254 pages and in-depth TOC on "Membrane Bioreactor Systems Market By Types [Hollow Fiber, Flat Sheet, Multi Tubular], Configuration [Internal (Submerged/Immersed) & External (Sidestream)] & Applications [Municipal & Industrial Wastewater Treatment] -Trends & Forecasts To 2017".
Early buyers will receive 10% customization on reports.

The report defines and segments the global MBR market with analysis and forecasting of the global volume and revenue for MBRs. It also identifies driving and restraining factors for the global MBR market with analysis of trends, opportunities, winning imperatives, burning issues, and challenges. The market is segmented and revenues are forecasted on the basis of major regions such as North America, Europe, Asia-Pacific (APAC), and Rest of the World (ROW). The key countries are covered and forecasted for each region. Further, market is segmented and revenues are forecasted on the basis of applications, types, and configurations of MBRs.

The global membrane bioreactor systems market is growing due to its ability to meet stringent effluent criteria along with its compact size and less operational cost as compare to other systems and equipments which are use for wastewater treatment. According to WHO, about one fifth of the world's population resides in areas where water is physically scarce, while one fourth face scarcities due to lack of infrastructure to transport water. Governments and industries have realized the importance of wastewater treatment, as a necessity and also as means to improve the bottom line. Stringent legislations for the implementation of the treatment facilities, combined with the space and operational advantages that MBRs provide, are expected to be key drivers of the market going forward. The sophistication and high capital costs associated with the system could however prove to be key obstacles.

APAC holds major market share in membrane bioreactor systems market. Europe is the second largest consumer. Countries in this region such as China and Japan use membrane bioreactors extensively for water reuse purpose in municipal application. With new factors coming into play, the MBR technology is now beginning to mature and will continue to penetrate further in the wastewater effluent treatment market.

APAC market share is 38% in the global MBR revenue market; Europe has 17% of share. However it is still the APAC region which is on the rise with a CAGR of 15.1% from 2012 to 2017. The MBR market by application is segmented into key segments as municipal and industrial wastewater treatments. The municipal wastewater applications occupy a major share in the consumption market, and are expected to be the fastest growing segment, going ahead.

Among the various types of MBR marketed, hollow fiber and flat sheet cover the major market of the membrane bioreactor, which is approximately 95.3% of the overall membrane bioreactor market. Selection is based on an evaluation of various criteria, including packing density, investment cost, fouling tendency, cleaning and operating costs, and membrane replacement costs.

The MBR market report also touches on various other important aspects of the market. It includes an analysis of the competitive landscape. In addition, 22 key players of this market have also been profiled.

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals [ ], consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defence and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website

Mr. Rohan
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-6006-441
MarketsandMarkets Blog @

SOURCE MarketsandMarkets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
2. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
3. Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List
4. StemCyte Adds World Class Talent to its North America and Global Operations
5. Sequenom Named to NASDAQ Global Select Market
6. Synthetic Biology: Emerging Global Markets
7. MacroGenics Receives Milestone Payment as Part of Its Global DARTâ„¢ Alliance with Boehringer Ingelheim
8. Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference
9. Hemodialysis Machine Industry 2012 Global & China Market Research Report - ReportsnReports
10. MarketsandMarkets: Global Seed Treatment Market worth $3430.3 Million by 2016
11. Accuray Surpasses 600 Installations Globally
Post Your Comments:
(Date:11/25/2015)... Md. , Nov. 25, 2015  PharmAthene, Inc. ... Directors has adopted a stockholder rights plan (Rights Plan) ... net operating loss carryforwards (NOLs) under Section 382 of ... --> PharmAthene,s use of its NOLs ... "ownership change" as defined in Section 382 of the ...
(Date:11/25/2015)... 2015 Studies reveal the differences ... and pave the way for more effective treatment for one ...   --> --> ... problems in cats, yet relatively little was understood about the ... have been conducted by researchers from the WALTHAM Centre for ...
(Date:11/25/2015)... -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced today ... Neurocrine Biosciences, will be presenting at the 27th Annual ... . .   Listeners ... prior to the presentation to download or install any ... available on the website approximately one hour after the ...
(Date:11/25/2015)... ... November 25, 2015 , ... A long-standing partnership ... Professionals (OPBAP) has been formalized with the signing of a Memorandum of Understanding. ... OPBAP leaders Capt. Karl Minter and Capt. Albert Glenn Tuesday, November 24, 2015, ...
Breaking Biology Technology:
(Date:11/19/2015)... 2015  Based on its in-depth analysis of the ... with the 2015 Global Frost & Sullivan Award for ... presents this award to the company that has developed ... of the market it serves. The award recognizes the ... on customer base demands, the overall impact it has ...
(Date:11/18/2015)... 18, 2015  As new scientific discoveries deepen our ... other healthcare providers face challenges in better using that ... In addition, as more children continue to survive pediatric ... and old age. John M. Maris, M.D ... of Philadelphia (CHOP) . --> John ...
(Date:11/17/2015)... 17, 2015 Paris from ... --> Paris from 17 th until ... biometrics innovation leader, has invented the first combined scanner in ... same scanning surface. Until now two different scanners were required: ... can capture both on the same surface. This innovation ...
Breaking Biology News(10 mins):